Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1H-Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease.
Journal: Journal of medicinal chemistry
Published: December 08, 2022
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates.
DGAT2 Inhibition Alters Aspects of Triglyceride Metabolism in Rodents but Not in Non-human Primates.
Journal: Cell metabolism
Published: August 12, 2017
Prolylcarboxypeptidase (PrCP) inhibitors and the therapeutic uses thereof: a patent review.
Journal: Expert opinion on therapeutic patents
Published: July 13, 2017
Pyrazoles as non-classical bioisosteres in prolylcarboxypeptidase (PrCP) inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: January 12, 2014
Discovery and optimization of orally active cyclohexane-based prolylcarboxypeptidase (PrCP) inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: September 09, 2013
A new class of prolylcarboxypeptidase inhibitors, part 2: the aminocyclopentanes.
Journal: Bioorganic & medicinal chemistry letters
Published: January 03, 2012
A new class of prolylcarboxypeptidase inhibitors, part 1: discovery and evaluation.
Journal: Bioorganic & medicinal chemistry letters
Published: January 03, 2012
A method for the reductive scission of heterocyclic thioethers.
Journal: Organic letters
Published: November 10, 2011
Discovery of aminoheterocycles as potent and brain penetrant prolylcarboxypeptidase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: October 26, 2011
The discovery of non-benzimidazole and brain-penetrant prolylcarboxypeptidase inhibitors.
Journal: Bioorganic & medicinal chemistry letters
Published: August 24, 2011
Showing 1-11 of 11
Last Updated: 09/26/2026